Robel Hussen Kabthymer, Jessica Danaher, Barbora de Courten
{"title":"地中海饮食与澳大利亚健康饮食指南(AGHE)对身体成分和葡萄糖代谢的影响:一项随机对照试验。","authors":"Robel Hussen Kabthymer, Jessica Danaher, Barbora de Courten","doi":"10.1111/dom.16458","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>The Mediterranean diet has been extensively studied and shown to reduce chronic disease risk. The Australian Guide to Healthy Eating (AGHE) offers a balanced dietary framework tailored to Australian habits, yet its comparative efficacy with the Mediterranean diet remains unexplored. Thus, this study aims to compare the efficacy of the Mediterranean diet with AGHE on body composition and glucose metabolism.</p><p><strong>Materials and methods: </strong>We conducted a randomised controlled trial including 57 participants (median age 31, IQR: 25-37 years; 71.9% female, BMI = 25.1 kg/m<sup>2</sup>), with 23 participants randomised to the Mediterranean diet and 34 participants to the AGHE diet for eight weeks. Paired t-tests were employed for within-group comparisons, and analysis of covariance (ANOVA) was used for between-group comparisons, adjusted for age and baseline observations.</p><p><strong>Results: </strong>The Mediterranean diet intervention resulted in a significant decrease in waist circumference (-1.3 cm, p = 0.043), body fat percentage (-1.8%, p = 0.014), resting metabolic rate (RMR) (-17.9 kcal/day, p = 0.02) and fasting insulin concentration (-1.2 μIU/mL, p = 0.016), along with an increase in body lean mass percentage (1.7%, p = 0.015) compared to the AGHE group.</p><p><strong>Conclusion: </strong>The Mediterranean diet demonstrated greater efficacy in improving body composition and maintaining metabolic variables than the AGHE. These findings may support the use of the Mediterranean diet in improving health outcomes related to obesity and metabolic disorders. However, larger, well-designed clinical trials are needed to confirm these findings and explore underlying mechanisms.</p>","PeriodicalId":158,"journal":{"name":"Diabetes, Obesity & Metabolism","volume":" ","pages":""},"PeriodicalIF":5.4000,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Mediterranean diet vs. the Australian guide to healthy eating (AGHE) on body composition and glucose metabolism: A randomized controlled trial.\",\"authors\":\"Robel Hussen Kabthymer, Jessica Danaher, Barbora de Courten\",\"doi\":\"10.1111/dom.16458\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Aims: </strong>The Mediterranean diet has been extensively studied and shown to reduce chronic disease risk. The Australian Guide to Healthy Eating (AGHE) offers a balanced dietary framework tailored to Australian habits, yet its comparative efficacy with the Mediterranean diet remains unexplored. Thus, this study aims to compare the efficacy of the Mediterranean diet with AGHE on body composition and glucose metabolism.</p><p><strong>Materials and methods: </strong>We conducted a randomised controlled trial including 57 participants (median age 31, IQR: 25-37 years; 71.9% female, BMI = 25.1 kg/m<sup>2</sup>), with 23 participants randomised to the Mediterranean diet and 34 participants to the AGHE diet for eight weeks. Paired t-tests were employed for within-group comparisons, and analysis of covariance (ANOVA) was used for between-group comparisons, adjusted for age and baseline observations.</p><p><strong>Results: </strong>The Mediterranean diet intervention resulted in a significant decrease in waist circumference (-1.3 cm, p = 0.043), body fat percentage (-1.8%, p = 0.014), resting metabolic rate (RMR) (-17.9 kcal/day, p = 0.02) and fasting insulin concentration (-1.2 μIU/mL, p = 0.016), along with an increase in body lean mass percentage (1.7%, p = 0.015) compared to the AGHE group.</p><p><strong>Conclusion: </strong>The Mediterranean diet demonstrated greater efficacy in improving body composition and maintaining metabolic variables than the AGHE. These findings may support the use of the Mediterranean diet in improving health outcomes related to obesity and metabolic disorders. However, larger, well-designed clinical trials are needed to confirm these findings and explore underlying mechanisms.</p>\",\"PeriodicalId\":158,\"journal\":{\"name\":\"Diabetes, Obesity & Metabolism\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":5.4000,\"publicationDate\":\"2025-06-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetes, Obesity & Metabolism\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/dom.16458\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes, Obesity & Metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/dom.16458","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
摘要
目的:地中海饮食已被广泛研究并证明可以降低慢性疾病的风险。《澳大利亚健康饮食指南》(AGHE)提供了一个适合澳大利亚人习惯的均衡饮食框架,但其与地中海饮食的比较效果仍未得到探索。因此,本研究旨在比较地中海饮食与AGHE对机体成分和葡萄糖代谢的影响。材料和方法:我们进行了一项随机对照试验,包括57名参与者(中位年龄31岁,IQR: 25-37岁;71.9%为女性,BMI = 25.1 kg/m2),其中23名参与者随机分为地中海饮食组,34名参与者分为AGHE饮食组,为期8周。组内比较采用配对t检验,组间比较采用协方差分析(ANOVA),调整年龄和基线观察值。结果:与AGHE组相比,地中海饮食干预组腰围(-1.3 cm, p = 0.043)、体脂率(-1.8%,p = 0.014)、静息代谢率(RMR) (-17.9 kcal/d, p = 0.02)和空腹胰岛素浓度(-1.2 μIU/mL, p = 0.016)显著降低,体瘦质量率(1.7%,p = 0.015)显著增加。结论:与AGHE相比,地中海饮食在改善身体成分和维持代谢变量方面表现出更大的功效。这些发现可能支持使用地中海饮食改善与肥胖和代谢紊乱相关的健康结果。然而,需要更大规模、设计良好的临床试验来证实这些发现并探索潜在的机制。
Mediterranean diet vs. the Australian guide to healthy eating (AGHE) on body composition and glucose metabolism: A randomized controlled trial.
Aims: The Mediterranean diet has been extensively studied and shown to reduce chronic disease risk. The Australian Guide to Healthy Eating (AGHE) offers a balanced dietary framework tailored to Australian habits, yet its comparative efficacy with the Mediterranean diet remains unexplored. Thus, this study aims to compare the efficacy of the Mediterranean diet with AGHE on body composition and glucose metabolism.
Materials and methods: We conducted a randomised controlled trial including 57 participants (median age 31, IQR: 25-37 years; 71.9% female, BMI = 25.1 kg/m2), with 23 participants randomised to the Mediterranean diet and 34 participants to the AGHE diet for eight weeks. Paired t-tests were employed for within-group comparisons, and analysis of covariance (ANOVA) was used for between-group comparisons, adjusted for age and baseline observations.
Results: The Mediterranean diet intervention resulted in a significant decrease in waist circumference (-1.3 cm, p = 0.043), body fat percentage (-1.8%, p = 0.014), resting metabolic rate (RMR) (-17.9 kcal/day, p = 0.02) and fasting insulin concentration (-1.2 μIU/mL, p = 0.016), along with an increase in body lean mass percentage (1.7%, p = 0.015) compared to the AGHE group.
Conclusion: The Mediterranean diet demonstrated greater efficacy in improving body composition and maintaining metabolic variables than the AGHE. These findings may support the use of the Mediterranean diet in improving health outcomes related to obesity and metabolic disorders. However, larger, well-designed clinical trials are needed to confirm these findings and explore underlying mechanisms.
期刊介绍:
Diabetes, Obesity and Metabolism is primarily a journal of clinical and experimental pharmacology and therapeutics covering the interrelated areas of diabetes, obesity and metabolism. The journal prioritises high-quality original research that reports on the effects of new or existing therapies, including dietary, exercise and lifestyle (non-pharmacological) interventions, in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems. ‘Metabolism’ may relate to lipids, bone and drug metabolism, or broader aspects of endocrine dysfunction. Preclinical pharmacology, pharmacokinetic studies, meta-analyses and those addressing drug safety and tolerability are also highly suitable for publication in this journal. Original research may be published as a main paper or as a research letter.